As for therapeutic approaches that target the STAT3 pathway, a potential method was recently identified and includes the use of salicylic acid-based inhibitor, SH-4-54, which was found to be toxic to TMZ-resistant GBM cells[136]. This evidence concerns the gene STAT3 and glioblastoma.